Category: Client News
CBC News | New VTE treatment 80% effective and reduces hazard of bleeding, says McMaster researcher

Three months after health officials announced Canada’s first known case of rare, post-vaccination blood clots, an international team of researchers at McMaster University is developing a “highly effective” treatment for people with, or at risk of, blood clots. Prof. Jeffrey Weitz says data from a study, published in late July, showed that a single post-operative dose of abelacimab reduced the […]

Dartmouth Week | Covid vaccine facility breaks ground in Darthmouth

A biopharmaceutical company working to develop a new Covid-19 vaccine has officially begun construction on a new research and manufacturing facility in Dartmouth. Officials from around the South Coast visited the Dartmouth portion of the New Bedford Business Park on Aug. 3 to break ground outside the 45,000 square foot facility Tonix Pharmaceuticals will use.

Cannabis Wealth | 180 Life Sciences selects CBD analogue for clinical development

Drug development company 180 Life Sciences has announced the selection of its lead synthetic CBD analogue to move forward into clinical development for medicines. 180 Life Sciences, a biotechnology company that develops novel drugs to meet unmet needs in inflammatory diseases, fibrosis and pain, has selected a lead synthetic CBD analogue that is expected to move forward […]